623 related articles for article (PubMed ID: 25703054)
21. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
Panda AK
Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
[TBL] [Abstract][Full Text] [Related]
22. [Hepatitis E virus capsid protein production by high cell density culture of recombinant Escherichia coli].
Liu RS; He ZQ; Li SW; Yang KY; Xian YL; Pang SQ; Zhang J; Li YM; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):450-5. PubMed ID: 15971623
[TBL] [Abstract][Full Text] [Related]
23. High production in E. coli of biologically active recombinant human fibroblast growth factor 20 and its neuroprotective effects.
Tian H; Zhao Y; Chen N; Wu M; Gong W; Zheng J; Fernig DG; Jungbauer A; Wang D; Li X; Jiang C
Appl Microbiol Biotechnol; 2016 Apr; 100(7):3023-34. PubMed ID: 26603761
[TBL] [Abstract][Full Text] [Related]
24. Recombinant expression and characterization of biologically active protein delta homolog 1.
Kilian TM; Beck-Sickinger AG
Protein Expr Purif; 2015 Jun; 110():72-8. PubMed ID: 25688756
[TBL] [Abstract][Full Text] [Related]
25. Kinetics of inclusion body production in batch and high cell density fed-batch culture of Escherichia coli expressing ovine growth hormone.
Panda AK; Khan RH; Rao KB; Totey SM
J Biotechnol; 1999 Oct; 75(2-3):161-72. PubMed ID: 10553655
[TBL] [Abstract][Full Text] [Related]
26. Cloning, expression, and refolding of a secretory protein ESAT-6 of Mycobacterium tuberculosis.
Wang BL; Xu Y; Wu CQ; Xu YM; Wang HH
Protein Expr Purif; 2005 Feb; 39(2):184-8. PubMed ID: 15642469
[TBL] [Abstract][Full Text] [Related]
27. Production of recombinant mink growth hormone in E. coli.
Sereikaite J; Statkute A; Morkunas M; Radzevicius K; Borromeo V; Secchi C; Bumelis VA
Appl Microbiol Biotechnol; 2007 Feb; 74(2):316-23. PubMed ID: 17103160
[TBL] [Abstract][Full Text] [Related]
28. High production and optimization of the method for obtaining pure recombinant human prolactin.
Affonso R; Soares CR; Ribela MT; Bartolini P
Protein Expr Purif; 2018 Dec; 152():131-136. PubMed ID: 30076885
[TBL] [Abstract][Full Text] [Related]
29. A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E.
Ehgartner D; Sagmeister P; Langemann T; Meitz A; Lubitz W; Herwig C
Appl Microbiol Biotechnol; 2017 Jul; 101(14):5603-5614. PubMed ID: 28429059
[TBL] [Abstract][Full Text] [Related]
30. Optimized upstream and downstream process conditions for the improved production of recombinant human asparaginase (rhASP) from Escherichia coli and its characterization.
Kante RK; Vemula S; Somavarapu S; Mallu MR; Boje Gowd BH; Ronda SR
Biologicals; 2018 Nov; 56():45-53. PubMed ID: 30327235
[TBL] [Abstract][Full Text] [Related]
31. Expression and rapid purification of recombinant biologically active ovine growth hormone with DsbA targeting to Escherichia coli inner membrane.
Durrani FG; Gul R; Sadaf S; Akhtar MW
Appl Microbiol Biotechnol; 2015 Aug; 99(16):6791-801. PubMed ID: 26124068
[TBL] [Abstract][Full Text] [Related]
32. High pH solubilization and chromatography-based renaturation and purification of recombinant human granulocyte colony-stimulating factor from inclusion bodies.
Li M; Fan H; Liu J; Wang M; Wang L; Wang C
Appl Biochem Biotechnol; 2012 Mar; 166(5):1264-74. PubMed ID: 22212394
[TBL] [Abstract][Full Text] [Related]
33. Efficient refolding of the bifunctional therapeutic fusion protein VAS-TRAIL by a triple agent solution.
Fan J; Wang Z; Huang L; Shen Y
Protein Expr Purif; 2016 Sep; 125():68-73. PubMed ID: 26358405
[TBL] [Abstract][Full Text] [Related]
34. High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications.
Pizarro SA; Gunson J; Field MJ; Dinges R; Khoo S; Dalal M; Lee M; Kaleas KA; Moiseff K; Garnick S; Reilly DE; Laird MW; Schmelzer CH
Protein Expr Purif; 2010 Aug; 72(2):184-93. PubMed ID: 20302942
[TBL] [Abstract][Full Text] [Related]
35. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli.
Upadhyay V; Singh A; Panda AK
Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939
[TBL] [Abstract][Full Text] [Related]
36. [Cloning, expression, renaturation and purification of soluble hSCF].
Wang LL; Geng XD; Han H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):402-5. PubMed ID: 15207080
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a truncated form of recombinant porcine growth hormone generated in vitro during solubilization of inclusion bodies.
Puri NK; Cardamone M; Crivelli E; Traeger JC
Protein Expr Purif; 1993 Apr; 4(2):164-75. PubMed ID: 8471849
[TBL] [Abstract][Full Text] [Related]
38. Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2].
Shin CS; Hong MS; Bae CS; Lee J
Biotechnol Prog; 1997; 13(3):249-57. PubMed ID: 9190075
[TBL] [Abstract][Full Text] [Related]
39. Improved solubilization of recombinant human growth hormone inclusion body produced in Escherichia coli.
Sonoda H; Sugimura A
Biosci Biotechnol Biochem; 2008 Oct; 72(10):2675-80. PubMed ID: 18838803
[TBL] [Abstract][Full Text] [Related]
40. Efficient recovery of the functional IP10-scFv fusion protein from inclusion bodies with an on-column refolding system.
Guo JQ; Li QM; Zhou JY; Zhang GP; Yang YY; Xing GX; Zhao D; You SY; Zhang CY
Protein Expr Purif; 2006 Jan; 45(1):168-74. PubMed ID: 16125970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
